EFFICACY OF 2'3' DDI GIVEN ORALLY 2/DAY TO PATIENTS WITH AIDS OR ARC

艾滋病或弧光病患者每日 2 次口服 23 DDI 的功效

• 批准号: 3785252
• 负责人: HENRY S SACKS
• 金额: --
• 依托单位: MOUNT SINAI SCHOOL OF MEDICINE OF CUNY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3785252
• 关键词: 2'3' dideoxyinosine; AIDS therapy; HIV infections; disease /disorder prevention /control; drug administration rate /duration; drug adverse effect; human subject; human therapy evaluation; opportunistic infections; oral administration; pharmacokinetics

This study is designed to test the safety and effectiveness of a new drug Dideoxyiosine (DDI) in preventing infection and prolonging survival in HIV infected patients who are intolerant of zidovudine because of toxic effects on their blood cells.

这项研究旨在测试一种新药的安全性和有效性 二脱氧肌苷（DDI）在预防感染和延长生存期中的作用 艾滋病病毒感染者谁是不耐受齐多夫定，因为毒性 影响他们的血细胞。